Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38176 - 38200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	PLXDC1	57125	upregulated	entinostat results in increased expression of PLXDC1 mRNA	17q12	A21035
Entinostat	Investigational	PLXNC1	10154	downregulated	entinostat results in decreased expression of PLXNC1 mRNA	12q22	A21037
Entinostat	Investigational	PMAIP1	5366	upregulated	entinostat results in increased expression of PMAIP1 mRNA	18q21.32	A21037
Entinostat	Investigational	PMEPA1	56937	upregulated	entinostat results in increased expression of PMEPA1 mRNA	20q13.31	A21037
Entinostat	Investigational	PMM2	5373	upregulated	entinostat results in increased expression of PMM2 mRNA	16p13.2	A21037
Entinostat	Investigational	PMP2	5375	upregulated	entinostat results in increased expression of PMP2 mRNA	8q21.13	A21035
Entinostat	Investigational	PNISR	25957	downregulated	entinostat results in decreased expression of PNISR mRNA	6q16.2	A21035
Entinostat	Investigational	PNPLA3	80339	upregulated	entinostat results in increased expression of PNPLA3 mRNA	22q13.31	A21037
Entinostat	Investigational	PNPO	55163	upregulated	entinostat results in increased expression of PNPO mRNA	17q21.32	A21035
Entinostat	Investigational	PODXL	5420	upregulated	entinostat results in increased expression of PODXL mRNA	7q32.3	A21037
Entinostat	Investigational	POLE4	56655	downregulated	entinostat results in decreased expression of POLE4 mRNA	2p12	A21035
Entinostat	Investigational	POLR3G	10622	upregulated	entinostat results in increased expression of POLR3G mRNA	5q14.3	A21037
Entinostat	Investigational	PON1	5444	upregulated	entinostat results in increased expression of PON1 mRNA	7q21.3	A21035
Entinostat	Investigational	POPDC3	64208	upregulated	entinostat results in increased expression of POPDC3 mRNA	6q21	A21035
Entinostat	Investigational	POSTN	10631	upregulated	entinostat results in increased expression of POSTN mRNA	13q13.3	A21037
Entinostat	Investigational	POU2F3	25833	upregulated	entinostat results in increased expression of POU2F3 mRNA	11q23.3	A21037
Entinostat	Investigational	POU3F1	5453	downregulated	entinostat results in decreased expression of POU3F1 mRNA	1p34.3	A21037
Entinostat	Investigational	POU3F2	5454	downregulated	entinostat results in decreased expression of POU3F2 mRNA	6q16.1	A21037
Entinostat	Investigational	POU4F2	5458	downregulated	entinostat results in decreased expression of POU4F2 mRNA	4q31.22	A21035
Entinostat	Investigational	POU5F1	5460	upregulated	entinostat results in increased expression of POU5F1 mRNA	6p21.33	A21037
Entinostat	Investigational	POU5F1B	5462	downregulated	entinostat results in decreased expression of POU5F1B mRNA	8q24.21	A21035
Entinostat	Investigational	POU5F1B	5462	upregulated	entinostat results in increased expression of POU5F1B mRNA	8q24.21	A21037
Entinostat	Investigational	POU5F1P3	642559	upregulated	entinostat results in increased expression of POU5F1P3 mRNA	12p13.31	A21037
Entinostat	Investigational	POU5F1P4	645682	upregulated	entinostat results in increased expression of POU5F1P4 mRNA	1q22	A21037
Entinostat	Investigational	PPARA	5465	upregulated	entinostat results in increased expression of PPARA mRNA	22q13.31	A21037 A21035

Displaying entries 38176 - 38200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability